gavapsertib   Click here for help

GtoPdb Ligand ID: 14616

Synonyms: compound A22 [US20230271968]
Compound class: Synthetic organic
Comment: Gavapsertib is the INN for a serine/threonine kinase inhibitor with antineoplastic potential, that was contained within WHO INN Proposed List 135 (July 2026). It is one of the compounds claimed as ataxia telangiectasia and Rad3-related (ATR) kinase inhibitors in patents held by Beijing Tide Pharmaceutical [1]. This potentially links the INN to clinical lead TCC1727.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 92.78
Molecular weight 455.52
XLogP 2.36
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H]1COCCN1C2=NC3=C(C=NN3C(=C2)C4=C(C)N(C5=CC=CN=C5)N=C4C)C6=CC=NN6
Isomeric SMILES C[C@@H]1COCCN1C2=NC3=C(C=NN3C(=C2)C4=C(N(N=C4C)C5=CN=CC=C5)C)C6=CC=NN6
InChI InChI=1S/C24H25N9O/c1-15-14-34-10-9-31(15)22-11-21(33-24(28-22)19(13-27-33)20-6-8-26-29-20)23-16(2)30-32(17(23)3)18-5-4-7-25-12-18/h4-8,11-13,15H,9-10,14H2,1-3H3,(H,26,29)/t15-/m1/s1
InChI Key PDEJNQRPTDOBPE-OAHLLOKOSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
ATR inhibition blocks a cellular checkpoint that is crucial for repairing damaged DNA, and this mechanism leads to cell death in rapidly dividing cancer cells [2].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
ATR checkpoint kinase Hs Inhibitor Inhibition 8.7 pIC50 - 1
⤷ pIC50 8.7 (IC50 2x10-9 M) [1]